Qingdao, China

Qingqing Song

This inventor holds 1 USPTO granted patent. Top assignee: Qingdao Vland Biotech Group Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingqing Song. Retrieved from https://idiyas.com/inventor/qingqing-song-zymv47ds

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qingqing Song: Innovator in Biotechnology

Introduction

Qingqing Song is a notable inventor based in Qingdao, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work on enzyme technology.

Latest Patents

One of Qingqing Song's most recent patents is a PHYTASE MUTANT. This invention showcases his expertise in developing enzymes that can enhance the nutritional value of animal feed, thereby promoting better growth and health in livestock.

Career Highlights

Qingqing Song is currently employed at Qingdao Vland Biotech Group Co., Ltd. His work at this company has allowed him to focus on research and development in the biotechnology sector, leading to advancements that benefit both agriculture and animal husbandry.

Collaborations

Qingqing collaborates with talented coworkers, including Xiuxiu Wu and Xinpei Li. Their combined efforts contribute to the innovative environment at Qingdao Vland Biotech Group Co., Ltd.

Conclusion

Qingqing Song's contributions to biotechnology, particularly through his patent on PHYTASE MUTANT, highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in agricultural biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…